These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 36330)
21. Depot neuroleptics: side effects and safety. Marder SR J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):24S-29S. PubMed ID: 2870089 [TBL] [Abstract][Full Text] [Related]
22. [Treatment with neuroleptics is not dangerous for the patient. The risk of tardive dyskinesia is increased in overdosing]. Wiesel FA Lakartidningen; 1987 Sep; 84(40):3174-6. PubMed ID: 2890802 [No Abstract] [Full Text] [Related]
23. The prevalence of akathisia in patients receiving stable doses of clozapine. Chengappa KN; Shelton MD; Baker RW; Schooler NR; Baird J; Delaney J J Clin Psychiatry; 1994 Apr; 55(4):142-5. PubMed ID: 7915271 [TBL] [Abstract][Full Text] [Related]
24. [Prevention of tardive dyskinesia caused by neuroleptic therapy]. Perényi A Orv Hetil; 1981 Jul; 122(27):1627-30. PubMed ID: 6117046 [No Abstract] [Full Text] [Related]
25. Factors in the development of severe forms of tardive dyskinesia. Yassa R; Nair NP; Iskander H; Schwartz G Am J Psychiatry; 1990 Sep; 147(9):1156-63. PubMed ID: 1974745 [TBL] [Abstract][Full Text] [Related]
26. Does clozapine cause tardive dyskinesia? Kane JM; Woerner MG; Pollack S; Safferman AZ; Lieberman JA J Clin Psychiatry; 1993 Sep; 54(9):327-30. PubMed ID: 8104929 [TBL] [Abstract][Full Text] [Related]
27. [Tardive Dyskinesia induced by neuroleptics: a survey of 3140 patients in a psychiatric hospital]. Bourgeois M Encephale; 1977; 3(4):299-320. PubMed ID: 611013 [TBL] [Abstract][Full Text] [Related]
33. Depot neuroleptic therapy: an underutilized treatment option. Glazer WM; Kane JM J Clin Psychiatry; 1992 Dec; 53(12):426-33. PubMed ID: 1362569 [TBL] [Abstract][Full Text] [Related]
34. Risk factors for drug-induced parkinsonism in tardive dyskinesia patients. Hansen TE; Brown WL; Weigel RM; Casey DE J Clin Psychiatry; 1988 Apr; 49(4):139-41. PubMed ID: 2895762 [TBL] [Abstract][Full Text] [Related]
35. A therapeutic approach to tardive dyskinesia. Fahn S J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):19-24. PubMed ID: 2858474 [TBL] [Abstract][Full Text] [Related]
36. Intermittent neuroleptic treatment and risk for tardive dyskinesia: Curaçao Extrapyramidal Syndromes Study III. van Harten PN; Hoek HW; Matroos GE; Koeter M; Kahn RS Am J Psychiatry; 1998 Apr; 155(4):565-7. PubMed ID: 9546009 [TBL] [Abstract][Full Text] [Related]
37. Tardive dyskinesia. Casey DE West J Med; 1990 Nov; 153(5):535-41. PubMed ID: 1979705 [TBL] [Abstract][Full Text] [Related]
38. [Occurrence of tardive dyskinesia during neuroleptic treatment]. Fanget F; Henry E; Aimard G Presse Med; 1986 Dec; 15(43):2147-50. PubMed ID: 2884657 [TBL] [Abstract][Full Text] [Related]
39. Intermittent neuroleptic therapy and tardive dyskinesia: a literature review. Goldman MB; Luchins DJ Hosp Community Psychiatry; 1984 Dec; 35(12):1215-9. PubMed ID: 6150891 [TBL] [Abstract][Full Text] [Related]
40. Drug history and tardive dyskinesia. Smith RC; Strizich M; Klass D Am J Psychiatry; 1978 Nov; 135(11):1402-3. PubMed ID: 30289 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]